SurgOnc Today®

SSO Education Series—From Trials to Practice: Key Breast Cancer Insights from SSO 2026

21 min · 21 de may de 2026
Portada del episodio SSO Education Series—From Trials to Practice: Key Breast Cancer Insights from SSO 2026

Descripción

In this episode of SurgOnc Today, Drs. Kelly Hewitt and Austin Williams review key breast cancer presentations from the 2026 Society of Surgical Oncology Annual Meeting. They discuss real-world implementation of SOUND and INSEMA, evolving approaches to axillary management in the neoadjuvant setting, and emerging data on omission of axillary surgery. Additional highlights include outcomes with partial breast irradiation in the setting of variable endocrine therapy adherence and contemporary management of rare breast malignancies such as angiosarcoma. Together, they explore how these findings are shaping multidisciplinary decision-making and the continued evolution of surgical de-escalation in breast cancer care.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de SurgOnc Today®!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

100 episodios

episode SSO Education Series—From Trials to Practice: Key Breast Cancer Insights from SSO 2026 artwork

SSO Education Series—From Trials to Practice: Key Breast Cancer Insights from SSO 2026

In this episode of SurgOnc Today, Drs. Kelly Hewitt and Austin Williams review key breast cancer presentations from the 2026 Society of Surgical Oncology Annual Meeting. They discuss real-world implementation of SOUND and INSEMA, evolving approaches to axillary management in the neoadjuvant setting, and emerging data on omission of axillary surgery. Additional highlights include outcomes with partial breast irradiation in the setting of variable endocrine therapy adherence and contemporary management of rare breast malignancies such as angiosarcoma. Together, they explore how these findings are shaping multidisciplinary decision-making and the continued evolution of surgical de-escalation in breast cancer care.

21 de may de 202621 min